vTv Therapeutics Inc. Retained Earnings
vTv Therapeutics Inc. (VTVT) had Retained Earnings of -$315.61 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$315.61M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$302.56M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$326.69M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$319.55M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$315.61M 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$302.56M 10-Q · filed 2026-05-13 |
| 2025-12-31 | -$326.69M 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$319.55M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$310.86M 10-Q · filed 2025-08-12 |
| 2025-03-31 | -$304.81M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$299.72M 10-K · filed 2026-03-10 |
| 2024-09-30 | -$296.08M 10-Q · filed 2024-11-12 |
| 2024-06-30 | -$291.30M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$286.12M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$281.04M 10-K · filed 2025-03-20 |
| 2023-09-30 | -$281.19M 10-Q · filed 2023-11-09 |
| 2023-06-30 | -$280.81M 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$274.32M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$265.52M 10-K · filed 2024-03-13 |
| 2022-09-30 | -$267.06M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$253.30M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$247.66M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$248.83M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$259.00M 10-Q · filed 2021-11-09 |
| 2021-06-30 | -$273.11M 10-Q · filed 2021-08-04 |
| 2021-03-31 | -$274.73M 10-Q · filed 2021-05-05 |
| 2020-12-31 | -$290.04M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$253.34M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$268.87M 10-Q · filed 2020-08-03 |
| 2020-03-31 | -$252.70M 10-Q · filed 2020-05-07 |
| 2019-12-31 | -$233.52M 10-K · filed 2021-02-24 |
| 2019-09-30 | -$223.72M 10-Q · filed 2019-10-30 |
| 2019-06-30 | -$217.56M 10-Q · filed 2019-07-31 |
| 2019-03-31 | -$220.49M 10-Q · filed 2019-05-01 |
| 2018-12-31 | -$233.88M 10-K · filed 2020-02-21 |
| 2018-09-30 | -$188.99M 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$206.53M 10-Q · filed 2018-08-03 |
| 2018-03-31 | -$277.91M 10-Q · filed 2018-05-15 |
| 2017-12-31 | -$279.06M 10-K · filed 2019-02-26 |
| 2017-09-30 | -$263.67M 10-Q · filed 2017-11-01 |
| 2017-06-30 | -$232.82M 10-Q · filed 2017-08-02 |
| 2017-03-31 | -$248.92M 10-Q · filed 2017-05-03 |
| 2016-12-31 | -$215.49M 10-K · filed 2018-02-27 |
| 2016-09-30 | -$234.41M 10-Q · filed 2016-11-03 |
| 2016-06-30 | -$201.99M 10-Q · filed 2016-08-02 |
| 2016-03-31 | -$182.86M 10-Q · filed 2016-05-13 |
| 2015-12-31 | -$195.99M 10-K · filed 2017-02-24 |
| 2015-09-30 | -$211.65M 10-Q · filed 2015-11-13 |